Top Markets
#1 Helium Helium +38.47%
#2 Pons Pons +34.55%
#3 Seeker Seeker +24.94%
#4 pipedog pipedog +22.74%
#5 TENDIES TENDIES +20.24%
#6 UnifAI Network UnifAI Network +19.75%
#7 Bounce Bounce +16.14%
#8 Songbird Songbird +12.21%
#9 Zylo Ecosystem Zylo Ecosystem +11.36%
#10 Clearpool Clearpool +11.27%
Coin of the day
Helium Helium
設定
言語
日本
通貨
USD
テーマ
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
株式のランク #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
株価
$26.13
最終同期: 2026-08-28
時価総額
$873.45M
変化（1日）
-2.99%
変化（1年）
-
国
US
取引 SpyGlass Pharma, Inc. Common Stock (SGP)

カテゴリー

Healthcare
SpyGlass Pharma, Inc. Common Stock（SGP）のP/B比率
2026 時点のP/B比率 TTM: 0
SpyGlass Pharma, Inc. Common Stock の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
SpyGlass Pharma, Inc. Common Stock の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH